Hims & Hers Health, Inc. (HIMS) stock
Close on Nov 12, 2026Market cap $4.60BP/E –Yield –
Hims & Hers Health, Inc. grew revenue 29.8% to $2.87B over the twelve months to Sep 30, 2026. Operating income fell 302.1% to -$232.48M, moving the operating margin from 5.2% to -8.1%. Free cash flow was $8.22M, down 93.1% from a year earlier. At the latest close the market valued the company at $4.60B.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $4.60B
- P/E ratio
- –
- Price to sales
- 1.60
- Price to book
- 12.96
- Dividend yield
- –
- Free cash flow yield
- 0.18%
Fundamentals
- Revenue
- $2.87B
- Net income
- -$190.84M
- EPS, diluted
- -$0.83
- Free cash flow
- $8.22M
- Book value per share
- $1.52
- Diluted shares
- 234M
Trading
- Next earnings
- Feb 22, 2027 (estimated, after the close)
- Previous close
- $20.81
- Open
- $19.56
- Day's range
- $19.47 – $20.45
- Volume
- 13,670,500
- Average volume (20 days)
- 15,209,254
- Index membership
- S&P MidCap 400 (since May 2025), Russell 2000 (since Jun 2022), Russell 3000 (since Aug 2022)
- Beta (5 years)
- 2.04
- 52-week range
- $13.74 – $40.99
- RSI (14 days)
- 33.4
- Volatility (1 year)
- 92.8%
- Relative volume
- 1.07×
- WACC
- 15.1%
On 1 of our idea list: Most shorted (a warning list)
Index membership is inferred from the holdings of funds that track each index (IJH, SPMD, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2020, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | HIMS | S&P 500 | Difference | HIMS per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -35.6% | -2.7% | −32.9 pts | ||
| 3 months | -34.2% | -1.7% | −32.4 pts | ||
| Year to date | -39.2% | +11.9% | −51.1 pts | ||
| 1 year | -49.4% | +12.0% | −61.4 pts | ||
| 3 years | +189.7% | +78.2% | +111.5 pts | +42.6% | +21.2% |
| 5 years | +166.6% | +73.2% | +93.4 pts | +21.7% | +11.6% |
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Hims & Hers Health filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- News
- News
- News
- Results
About Hims & Hers Health
Services-Offices & Clinics of Doctors of Medicine
Hims & Hers Health, Inc. operates a digital consumer healthcare platform that connects patients with licensed healthcare professionals and fulfillment services. The company provides personalized access to prescription medications, compounded treatments, and over-the-counter wellness products focusing on areas such as sexual health, hair loss, dermatology, mental health, and weight management. Additionally, it offers comprehensive laboratory testing and health assessment services directly through its websites and mobile applications, serving consumers primarily on a recurring subscription model.
Company profile, executives and historyHims & Hers Health stock: common questions
What is Hims & Hers Health's stock price?
HIMS closed at $19.73 on Nov 12, 2026, down 5.19% on the day. Over the past 52 weeks it traded between $13.74 and $40.99.
What is Hims & Hers Health's market cap?
Hims & Hers Health was worth $4.60B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is HIMS's P/E ratio?
Hims & Hers Health lost money over the twelve months to Sep 30, 2026 (diluted EPS -$0.83), so it has no meaningful P/E ratio.
How much revenue does Hims & Hers Health make?
Hims & Hers Health reported revenue of $2.87B for the twelve months to Sep 30, 2026, up 29.8% from a year earlier.
Does Hims & Hers Health pay a dividend?
No. Hims & Hers Health has not paid a cash dividend over the last twelve months.
When does Hims & Hers Health report earnings next?
Hims & Hers Health is expected to report Q4 FY2026 results on Feb 22, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has HIMS stock performed over the past year?
Including dividends, HIMS returned -49.4% over the past year, against +12.0% for the S&P 500.
How many HIMS shares are sold short?
52M shares were sold short at the latest FINRA report, 24.86% of the float, or 5.8 days of average trading volume.
Who are Hims & Hers Health's competitors?
Companies most similar to Hims & Hers Health by business, industry and size include TDOC, AUNA, LFMD, STLN, CCM.
See a number that looks wrong?